Keeps, headquartered in United States, remains privately held in the healthcare-ecommerce space. No public ticker exists for the company.
Keeps has no published valuation.
No funding round for Keeps has been disclosed yet.
Northzone
GreycroftSSteadfast Venture CapitalFFirst RoundEERANorthzoneGreycroftSteadfast Venture CapitalKeeps offers FDA-approved hair loss medications delivered to your door, built around products that contain minoxidil and finasteride, ingredients the Food and Drug Administration has approved for preventing hair loss and promoting hair regrowth in men. The company targets men experiencing pattern baldness, noting that 2 out of 3 guys will experience hair loss by the age of 35.
Keeps is an online business based in the United States, running its consultations and prescriptions almost entirely online. The first online visit is free, and Trustpilot describes Keeps as the easiest way to keep your hair, pairing a doctor consultation with an ongoing personalized treatment plan.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Keeps.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Keeps availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Keeps included.
The closest healthcare-ecommerce peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Keeps is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
